Canaan VII

Canaan VII is an early-stage venture capital fund managed by Canaan Partners, a global firm established in 1987 and based in San Francisco, California. The fund focuses on investing in the software and technology, media, and telecommunications (TMT) sectors within the United States. Canaan Partners manages a diverse portfolio with over 190 exits and has invested in more than 250 companies across various industries, including fintech, healthcare, and digital health. The firm employs a team of experienced investment professionals who seek to support visionary entrepreneurs with innovative ideas, providing capital ranging from $1 million to $20 million across different stages of development. With approximately $5 billion under management across multiple funds, Canaan Partners continues to play a significant role in fostering growth within the technology and healthcare landscapes.

Brent Ahrens

General Partner

Brenton K. Ahrens

General Partner - West Coast

Nandu Anilal

Investor

John Balen

Partner - West Coast

Joydeep Bhattacharyya

General Partner - West Coast

Stephen Bloch

General Partner - East Coast

Laura Chau

Partner

Daniel T. Ciporin

General Partner

Colleen Cuffaro

Partner

Brendan Dickinson

General Partner

Peter Farina Ph.D

Executive in Residence - East Coast

Rayfe Gaspar-Asaoka

Partner

Julie Grant

General Partner - West Coast

Nairi Hourdajian

Vice President, Marketing and Communications

Wende Hutton

General Partner - West Coast

Maha Ibrahim

General Partner

Deepak Kamra

General Partner - West Coast

Nina Kjellson

General Partner

Ehud Levy

Co-Founder & General Partner, Canaan Partners Israel

Jared Newman

Investor

John Pacifico

General Partner, Chief Operating Officer, and Chief Financial Officer - East Coast

Hootan Rashidifard

Principal

Guy Russo

General Partner - East Coast

Timothy Shannon

General Partner - East Coast

Hrach Simonian

General Partner

Bob Williams

Venture Partner

Eric Young

Co-Founder and Partner - West Coast

Past deals in Series B

Lily AI

Venture Round in 2022
Lily AI is the leader in predictive psychographics for retail e-commerce. Consumer spending online for apparel now accounts for over 27% of all clothing sales. Retailers need to understand each consumer’s emotional context while they are actively shopping. Lily AI combines deep product tagging with deep, real-time psychographic analysis to determine the active state of mind of each shopper, and turns that into precise and timely recommendations. These recommendations are proven to lead to higher conversions and lower return rates. Lily AI (lilystyle.ai) was founded by two women who believe clothes to reflect how they feel about themselves. The company is venture-backed and headquartered in Mountain View, CA.

Dusty Robotics

Series B in 2022
Dusty Robotics, Inc. specializes in automated layout services for the construction industry. Founded in 2018 and headquartered in Mountain View, California, the company develops layout robots that integrate Building Information Modeling (BIM) data directly onto construction sites. This innovation streamlines the workflow by eliminating manual processes associated with traditional BIM practices. Dusty Robotics serves a diverse clientele, including owners, general contractors, subcontractors, and builders, facilitating the digital transformation of job sites through advanced robotic automation.

Lev

Series B in 2022
LEV is a tech-enabled commercial real estate broker for capital markets advisors. They use machine learning and artificial intelligence to identify the best financing scenarios and lenders for every deal, based on historical data and lender activity. The company technology quickly and automatically organizes deal- and property-related documents, while digitizing them for easier management and storage. LEV was founded in 2019 and is headquartered in New York, NY, USA.

BoostUp.ai

Series B in 2022
BoostUp.ai, Inc operates a sales intelligence platform. Its platform analyzes risk at macro and micro levels, such as forecast, pipeline, deals, and seller behavior to turn unstructured data into actionable insights. The company is based in Santa Clara, California.

Hermeus

Series B in 2022
Hermeus is developing Mach 5 aircraft to speed up the global transportation network. Mach 5 flight is not just supersonic, it's hypersonic. At these speeds, a flight from New York to London is 90 minutes, rather than 7 hours. Its aircraft massively reduces flight times and increases safety for the long haul and business class air travel, enabling businesses to operate with minimal changes to current aviation infrastructure. The company was founded in 2018 and headquartered in Atlanta, Georgia.

Hermeus

Series B in 2022
Hermeus is developing Mach 5 aircraft to speed up the global transportation network. Mach 5 flight is not just supersonic, it's hypersonic. At these speeds, a flight from New York to London is 90 minutes, rather than 7 hours. Its aircraft massively reduces flight times and increases safety for the long haul and business class air travel, enabling businesses to operate with minimal changes to current aviation infrastructure. The company was founded in 2018 and headquartered in Atlanta, Georgia.

Taptap Send

Series B in 2021
Taptap Send is an app that lets immigrants send money back home to Africa instantly and at very low prices. Since launching in summer 2018, it has already moved tens of millions of dollars and reached tens of thousands of customers. It is live in seven European countries, and support payments into Senegal, Mali, Zambia, Ghana and the Ivory Coast, with more countries launching soon.

Apex.AI

Series B in 2021
Apex.AI, Inc. develops software products specifically designed for autonomous mobility systems. Its primary offering, Apex.OS, is a software framework that simplifies the complexity of hardware, middleware, and interfaces, providing users with safe and secure APIs. The company also offers Apex.Autonomy, which is tailored for safety-critical applications. Additionally, Apex.AI features MARV.Automotive, an extensible data management platform that facilitates data transfer from vehicles to the cloud, enabling dynamic search-based analytics, log analysis, real-time algorithm execution, and data introspection through graphical tools. Founded in 2017 and headquartered in Palo Alto, California, Apex.AI aims to create robust and reliable operating systems for autonomous vehicles.

Edge Impulse

Series B in 2021
Edge Impulse is a platform designed to facilitate the development of intelligent devices through embedded machine learning, specifically TinyML. It streamlines the process of building, deploying, and scaling embedded machine learning applications, enabling developers to create innovative solutions more efficiently. The platform allows for the easy collection of real sensor data and supports live signal processing, transforming raw data into neural networks. Additionally, it provides tools for testing and deploying applications across various target devices, ultimately aiming to drive positive societal change through the effective use of machine learning technology.

Sounding Board, Inc

Series B in 2021
Sounding Board Labs, Inc. is a technology company headquartered in Aliso Viejo, California, that specializes in providing a comprehensive platform for leadership coaching and development. Established in 2016, the company offers personalized coaching plans tailored to the needs of leaders and new managers, utilizing various communication methods including phone, video, and chat. The platform features a high-quality network of qualified coaches and encompasses tools for easy administration, progress tracking, and reporting on coaching effectiveness. Sounding Board serves a diverse range of global enterprises across 11 countries, emphasizing a modern user experience tailored to different learning styles. With a strong focus on scaling coaching initiatives organization-wide, the company aims to be a leading provider of coaching solutions for businesses around the world.

Reibus

Series B in 2021
Reibus operates an independent online B2B marketplace focused on the buying and selling of prime and excess materials for industrial markets. The platform aims to enhance price performance, streamline time to market, and broaden market reach while lowering sales and marketing costs compared to traditional methods. For sellers, Reibus provides a means to efficiently list their materials, while buyers benefit from increased selection, market transparency, and a simplified procurement process. A key feature of the marketplace is its proprietary search tool, which facilitates a more efficient and user-friendly experience for both parties, expediting what is typically a cumbersome sourcing process.

Clutch

Series B in 2021
Clutch Canada Inc. is an online platform that specializes in the sale of used cars, allowing customers to search, experience, finance, and purchase vehicles from the comfort of their homes. Founded in 2017 and headquartered in Bedford, Canada, the company serves regions including Nova Scotia, Halifax, Toronto, and Dartmouth. Clutch distinguishes itself by providing detailed listings that feature images of vehicle condition, comprehensive CarFax reports, and 360-degree views of both the interior and exterior. The company emphasizes transparency by having no hidden fees and offers a seven-day money-back guarantee on all purchases. Additionally, Clutch provides services such as test drives, mechanical inspections, and direct delivery to enhance the customer experience.

TrueFort

Series B in 2021
TrueFort Fortress is a comprehensive, real-time cloud and application workload protection solution that secures the largest, most targeted and most dynamic, part of the enterprise attack surface … its application environment. It leverages telemetry from your existing agents and delivers more value than point or infrastructure-focused solutions. Best of all, it is a single console, policy, and reporting system from which to measure, control and immediately improve your risk posture.

Kepler Communications

Series B in 2021
Kepler Communications Inc. is a satellite communications company focused on establishing a network for space-based connectivity that integrates space stations, habitats, and devices with orbiting satellites. The company offers various services, including Low-Earth Orbit (LEO) solutions that provide global coverage, PolarConnect for organizations operating in extreme environments, and Global Data Service, which facilitates high-bandwidth data transfer between remote sites and the internet. Additionally, Kepler is developing everywhereIOT, a satellite service designed to deliver reliable connectivity for Internet of Things (IoT) devices worldwide. By addressing the challenges of intermittent connectivity for non-geostationary satellites, Kepler aims to reduce the reliance on expensive ground infrastructure and enhance real-time communication capabilities for diverse industries such as maritime, natural resources, research, defense, and logistics. Founded in 2015 and headquartered in Toronto, Canada, Kepler has launched several satellites and is advancing its LEO constellation deployment.

Archipelago

Series B in 2021
Archipelago uses AI to digitize risk for large owners of commercial property to increase their resiliency and lower their total cost of risk, including by improving their insurance outcomes.

Tyra Biosciences

Series B in 2021
Tyra Biosciences is a clinical-stage biotechnology company based in Carlsbad, California, focused on developing small molecule therapies for cancer treatment. Founded in 2018, the company aims to address drug resistance in oncology by targeting specific pathways associated with acquired resistance. Tyra Biosciences employs its proprietary precision medicine platform, SNÅP, to facilitate rapid drug design through molecular snapshots, enabling the prediction of genetic alterations that may lead to resistance against existing therapies. The company's lead product candidate, TYRA 300, is an FGFR3 selective inhibitor, primarily aimed at treating patients with metastatic urothelial carcinoma of the bladder and urinary tract. Through innovative approaches, Tyra Biosciences seeks to create next-generation precision medicines that significantly improve treatment outcomes for cancer patients.
Day One Biopharmaceuticals is a biotechnology company focused on developing new cancer therapies for patients of all ages. The company understands that advances in cancer research now enable drug developers to identify children and adults who may benefit from the same medicine. They develop new therapies that meet the critical needs of people of all ages living with cancer starting from the biology of childhood cancer. Day One Biopharmaceuticals also focuses its efforts to bring the best medicines to families receiving the life-altering news of a new cancer diagnosis and the need for a treatment plan. It prioritizes programs that can be rapidly brought to market for both younger and older patients. The company's goal is to license and acquire the most promising products from research institutions as well as for biotechnology and pharmaceutical companies. Day One Biopharmaceuticals was founded in 2018 and is headquartered in South San Francisco, CA, USA.

Axis Security

Series B in 2020
Axis Security Inc. is a private application access company founded in 2018 and based in California. It specializes in a zero-trust cloud security platform that enables organizations to manage access for employees, partners, and stakeholders securely. Through its innovative Application Isolation Technology, Axis Security ensures that users have access only to the necessary resources, minimizing excess access and associated risks. This approach transforms open networks and vulnerable applications into secure resources, allowing businesses to operate and expand with confidence. The company's focus on cloud security and analytics solutions positions it as a key player in the evolving landscape of cybersecurity.

Instrumental

Series B in 2020
Instrumental, Inc. specializes in developing software that enhances the efficiency of assembly lines by enabling them to operate autonomously, learn, and adapt to various processes. Founded by former Apple engineers Anna-Katrina Shedletsky and Samuel Weiss, the company aims to address inefficiencies in manufacturing, ultimately saving significant costs related to scrap and rework. Instrumental's software allows manufacturers to quickly identify and resolve issues on their assembly lines, thereby preventing production delays and improving yield rates. The service is employed by leading manufacturers globally and focuses on analytics that provide insights into assembly line performance, allowing engineers to evaluate part dimensions and diagnose problems in real-time without needing physical access to the production environment. Based in Saint Paul, Minnesota, Instrumental combines its software capabilities with a range of consulting and integration services to support both commercial enterprises and government agencies in optimizing their operations.

READY Robotics

Series B in 2020
READY Robotics enables manufacturers to more easily deploy robots to the factory floor through a patented technology platform that combines a very easy to use programming interface and plug'n'play hardware. The company encourages manufacturers to be more competitive through the line of intuitive-to-use, easy to control industrial robotic software called Forge, which is a suite of products that requires minimum installation effort, no robotic or programming experience necessary. READY Robotics was founded on 2016 and is headquartered in Columbus, Ohio.

Berkshire Grey

Series B in 2020
Berkshire Grey, Inc. specializes in developing artificial intelligence-driven robotic and automated material handling systems aimed at enhancing omnichannel fulfillment. Founded in 2013 and based in Lexington, Massachusetts, the company offers a range of solutions, including AI software, robotic arms, mobile robotic systems, and advanced sorting technologies. Its systems leverage artificial intelligence, computer vision, and machine learning to automate tasks traditionally performed by humans, thereby increasing accuracy and throughput in logistics and supply chain operations. Berkshire Grey's technology is designed to handle diverse products and packaging types, providing a significant competitive advantage to its customers. The company primarily generates its revenue from North America and operates as a subsidiary of SoftBank Group Corp.

nTopology

Series B in 2019
nTopology, Inc. develops engineering design software that enhances manufacturing processes. Its primary offering, nTopology, allows engineers to create lightweight and optimized parts tailored to functional requirements. The software integrates design, simulation, and advanced manufacturing into a cohesive workflow, addressing geometry bottlenecks and enhancing team collaboration. Key features include Lightweighting, Architected Materials, Topology Optimization, Additive Manufacturing, and Design Analysis. nTopology's tools enable precise control over spatial variations, facilitating a broader range of designs and effective utilization of analysis data. The company serves various industries, including aerospace and defense, medical, automotive, consumer products, and education. Founded in 2013 and based in New York, nTopology aims to redefine engineering design tools for advanced manufacturing.

CompStak

Series B in 2019
CompStak, Inc. is a New York-based company that operates a crowd-sourced online database specializing in commercial lease comparisons. Founded in 2011, CompStak provides a platform where brokers, landlords, appraisers, and researchers can exchange detailed information on completed commercial lease transactions. The database includes essential data such as tenant names, addresses, rental rates, square footage, landlord concessions, and broker details. This comprehensive information is utilized by various stakeholders, including real estate private equity firms, banks, asset managers, REITs, and hedge funds, to conduct valuations and analyses of potential investments. Additionally, institutional property owners leverage CompStak's data to benchmark their assets against the market. The company has established a strategic partnership with Knowledge Cubed to enhance its data offerings.

Gen.G esports

Series B in 2019
Gen.G esports is a professional esports organization founded in 2017, with headquarters in Seoul, South Korea, and additional offices in Los Angeles, California, and Shanghai, China. The organization connects the U.S. and Asia, owning and operating top-tier teams in leading esports markets, including the Seoul Dynasty in the Overwatch League and championship-winning teams in League of Legends. Gen.G has garnered recognition for its competitive achievements, with its teams winning seven global championships. The organization focuses on premier team management, player management, coaching, and fan engagement services, while also providing a platform for global brands to connect with gaming enthusiasts. Additionally, Gen.G is committed to promoting inclusivity in gaming through initiatives such as #TeamBumble, which supports women in gaming, and the Gen.G Elite Esports Academy, the first fully integrated academic esports program. Through its diverse portfolio and innovative programs, Gen.G aims to empower both fans and athletes in the evolving landscape of esports.

Roman

Series B in 2019
Roman Health Medical LLC operates Roman, a platform for adult men who are experiencing erectile dysfunction and prefer to receive treatment online. The company was incorporated in 2017 and is headquartered in New York, New York.

ScaleFactor

Series B in 2019
ScaleFactor provides accounting and finance software with automated bookkeeping, proactive alerts, and other features. It is a smart accounting and finance software that changes the way modern businesses operate. By automating complex accounting tasks and translating financial information into usable business insights, ScaleFactor is enabling business owners, managers, and entrepreneurs to focus on what they love: running and growing their business. The company was founded in 2014 and is headquartered in Austin, Texas.

Embroker

Series B in 2018
Embroker, Inc. is a digital insurance brokerage that specializes in providing insurance services for small and mid-sized businesses. Founded in 2015 and headquartered in San Francisco, with additional offices in Chicago and Boston, the company utilizes an online platform that enables clients to buy, manage, and analyze their commercial insurance policies efficiently. This platform allows users to share, request, and track proof of coverage through digital certificates of insurance and provides tools for real-time claims tracking. Embroker offers a variety of insurance products, including Commercial General Liability, property insurance, professional liability, and employee benefits, among others. The company also facilitates peer comparison, helping clients benchmark their policies against industry standards. By combining technology with brokerage expertise, Embroker aims to simplify the insurance process and enhance value for its clients in the competitive property and casualty insurance market.

Dragos

Series B in 2018
Dragos is a cybersecurity company focused on protecting critical infrastructure across various industries, including power, water utilities, energy, and manufacturing. The company develops an integrated software platform that offers essential visibility into industrial control systems (ICS) and operational technology (OT) networks, enabling organizations to identify and address potential threats before they escalate. Dragos also adapts its solutions for emerging applications, such as the Industrial Internet of Things (IIoT). Headquartered in the Washington, DC area, Dragos has a global presence with regional offices in Canada, Australia, New Zealand, Europe, and the Middle East. The company is committed to safeguarding civilization through its expertise in industrial cybersecurity.

OncoResponse

Series B in 2018
OncoResponse Inc. is an immuno-oncology company based in Houston, Texas, focused on discovering new cancer immunotherapies and therapeutic antibodies. The company collaborates with MD Anderson Cancer Center to utilize the I-STAR™ platform, which analyzes the human memory B-cell repertoire of patients who have demonstrated exceptional responses to immunotherapy, referred to as "Elite Responders." By studying these patients, OncoResponse aims to harness the human immune system to identify fully human monoclonal antibodies and novel targets. This approach is intended to facilitate the development of innovative antibody-derived therapeutics for cancer treatment.

Cargomatic

Series B in 2018
Cargomatic, Inc. operates an online platform that connects shippers with carriers real-time. It makes available pre-screened and qualified carriers for shippers. The company offers its services to the customers in Southern California. Cargomatic, Inc. was incorporated in 2013 and is based in Venice, California. Cargomatic, Inc. operates as a subsidiary of Genesee & Wyoming Inc.

Kustomer

Series B in 2018
Kustomer, Inc. is a customer service software company that specializes in customer relationship management (CRM). Founded in 2015 and headquartered in New York City, Kustomer offers an omnichannel platform that consolidates data from various sources, enabling businesses to manage customer inquiries efficiently. The software provides a unified view of customers' buying history and previous interactions, allowing service agents to address issues such as refund requests or recurring questions with greater context. Kustomer's platform is utilized by prominent brands, enhancing their customer service capabilities by delivering seamless support experiences. The company also has an office in Durham, North Carolina.

PACT Pharma

Series B in 2018
Pact Pharma is a developer of personalized adoptive T cell therapies designed for the eradication of solid tumors.The company's therapies help in the identification of neo-epitopes that serve as private mutations for each patient's cancer as well as creates an opportunity to engineer autologous T cells that target and kill tumors expressing these neo-antigens, enabling physicians to recognize and remove each patient's cancer cells.

Mynd

Series B in 2018
Mynd is a property management platform that simplifies rental management services for property owners. The platform provides real-time insights into rental income, vacancies, and maintenance requests, allowing users to efficiently manage their properties from anywhere. Through its mobile app, Mynd offers up-to-date performance data, enabling landlords to track rent payments, approve expenses, and stay informed about local market trends. The company's focus on leveraging technology and data aims to enhance the overall management experience and maximize returns for property owners. Mynd is headquartered in the East Bay of San Francisco and is dedicated to providing unparalleled service to its clients.

Vineti

Series B in 2018
Vineti is a commercial cloud-based platform that expands patient access to life-saving cells and gene therapies. The software solution offers an independent, purpose-built enterprise solution that is essential for enabling the growth and wide distribution of transformative personalized therapeutics, such as CAR-T cell therapies, for the treatment of late-stage cancer. The Vineti Personalized Therapy Management (PTM) ® platform automates patient-centric supply chains for a wide range of advanced therapies, in all phases of clinical development and commercial operations. Veneti aims to solve the key challenges patients, medical providers, pharmaceutical companies, and regulators face in the delivery and commercialization of personalized medicine. Amy DuRoss, Heidi M. Hagen, Malek Faham, Razmik Abnous, and Stephen Ting co-founded Vineti in San Francisco, California in 2016.

IDEAYA Biosciences

Series B in 2018
IDEAYA Biosciences is an oncology-focused biotechnology company based in South San Francisco, California, dedicated to the discovery and development of targeted therapeutics for genetically defined patient populations. The company specializes in precision medicine using molecular diagnostics and synthetic lethality approaches to address cancer treatment. Its lead product candidate, IDE196, is a protein kinase C inhibitor currently undergoing Phase 1/2 clinical trials for cancers associated with GNAQ or GNA11 gene mutations. IDEAYA's preclinical pipeline includes programs targeting various mechanisms related to DNA damage and repair, such as MAT2A for tumors with MTAP deletions, Pol-theta for homologous recombination deficiency, and PARG for BRCA2 mutation context. The company collaborates with Cancer Research UK and the University of Manchester to develop small molecule inhibitors of Poly (ADP-ribose) glycohydrolase, while also engaging in partnerships for clinical trials with Pfizer and GlaxoSmithKline. Founded in 2015, IDEAYA aims to advance innovative therapies for enhancing immunotherapy responses and improving patient outcomes in oncology.

Imanis Data

Series B in 2018
Imanis Data is a venture-backed startup based in Silicon Valley, currently operating in stealth mode. The company focuses on developing a next-generation data management platform aimed at transforming the big data and storage industry. With a team that possesses extensive expertise in storage and big data, Imanis Data is working on innovative solutions for fast data backup and recovery. The company is expected to reveal more about its groundbreaking products and developments as it transitions out of stealth mode.

Contentsquare

Series B in 2018
Contentsquare offers a platform that analyzes customer behavior through billions of anonymous interactions across web, mobile, and app environments, while adhering to data privacy regulations such as the EU GDPR and California CCPA. The platform synthesizes various data points, including content, user experience, product details, pricing, acquisition channels, and technical performance, to generate insights and AI-driven recommendations. These insights aim to enhance digital performance throughout the customer journey, ultimately helping businesses improve revenue, engagement, and growth. With a client base exceeding 700 enterprise customers, Contentsquare serves notable companies such as American Express, Best Buy, Dell, Ikea, LVMH, T-Mobile, Salesforce, Sephora, and Toyota.

Ladder

Series B in 2018
Ladder Financial Inc. operates an online platform that provides term life insurance services in the United States. Founded in 2015 and based in Palo Alto, California, the company offers instant, fully underwritten life insurance policies with competitive pricing and transparency, featuring no hidden fees. Ladder's model allows customers to adjust or cancel their coverage at any time, addressing the significant life insurance gap affecting underinsured families and communities. By leveraging artificial intelligence and a direct-to-consumer approach, Ladder aims to make life insurance more accessible and fair for its clients.

MindTickle

Series B in 2017
MindTickle Interactive Media Pvt Ltd. provides a social learning platform for organizations and corporations in various industries. Its platform enables businesses, trainers, and individuals to transform their existing online content into an interactive learning experience; use game mechanics, such as points, medals, badges, and leader boards to increase learner motivation and engagement; create learner engagement and peer-to-peer learning by leveraging the power of social mechanics; and measure and track the effectiveness Web-based training programs through real-time charts and dashboards. The company’s platform is used for new hire orientation, policy refreshment, and employee engagement applications. MindTickle Interactive Media Pvt Ltd. was founded in 2011 and is based in Pune, India.

PerimeterX

Series B in 2017
PerimeterX, Inc. is a cybersecurity firm that specializes in detecting and preventing automated attacks on web infrastructure. Founded in 2014 and headquartered in San Mateo, California, with additional offices in London, Miami, and Tel Aviv, the company offers a range of security solutions designed to protect organizations from malicious web behavior. Its flagship product, PerimeterX Bot Defender, utilizes behavioral analytics to identify and mitigate various types of bot attacks, including account abuse, web scraping, and marketing fraud. The company also provides specialized solutions for mobile applications and application programming interfaces (APIs), ensuring comprehensive protection across different platforms. Serving industries such as e-commerce, travel, hospitality, and enterprise software, PerimeterX is recognized for its advanced threat protection technology that effectively distinguishes between legitimate users and automated threats.

Vivace Therapeutics

Series B in 2017
Vivace Therapeutics is a venture-backed start-up dedicated to discovering and developing cancer therapeutics by targeting a novel pathway. At Vivace Therapeutics, they pursue their work with passion, driven by a conviction to help people fight cancer and live life to the fullest. Based in the San Francisco Bay Area, Vivace Therapeutics is an oncology-focused portfolio-based drug discovery and development company adopting a capital-efficient and modality-indifferent approach to bring novel therapies to patients in need. Their experienced management team and world-class scientists work to advance promising drugs and therapeutic technologies that they believe can help conquer cancer.

Iterum Therapeutics

Series B in 2017
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing anti-infectives for multi-drug resistant pathogens in Ireland and the United States. The company is developing sulopenem, a novel penem anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was founded in 2015 and is headquartered in Dublin, Ireland.

Onkos Surgical

Series B in 2017
Onkos Surgical Inc. is a company that specializes in providing innovative technologies and solutions tailored for surgical oncologists. Established in 2014 and based in Parsippany, New Jersey, the company focuses on addressing the complexities of cancer treatment through its offerings, which include GenVie, a magnesium bone scaffolding technology, and the ELEOS Proximal Tibia, a 3D-printed limb salvage replacement. Onkos Surgical aims to enhance the capabilities of surgical oncologists, recognizing the need for personalized and diverse solutions, particularly for pediatric patients and others with unique medical requirements.

UNIFi Software

Series B in 2017
UNIFi solves ubiquitous data acquisition and integration problems that continually plague enterprises since the dawn of data warehousing. The landscape of data analysis that enterprises are embarking on today has significantly advanced in just a few years' time. The days of building an enterprise data warehouse to report on financial status or sales overtime is no longer a competitive advantage; in today's world doing this well is now considered a cost of doing business. The core problem that has arisen in this new era of Analytics is business users have not been enabled to participate in the most critical part of the process that has the biggest impact on time to insight. With the advent of the Hadoop data storage and processing platform, this has created a unique opportunity to build an application that enables the business to acquire data, integrate it, enrich it, and load it into a flexible environment where agile and iterative analytics can occur. UNIFi is building the first of its kind business application that combines Big Data integration processing layered with an elegant and simple user experience that will dramatically increase productivity and time to insight.

Apartment List

Series B in 2016
Apartment List is a smart, simple, and seamless renting platform that’s dedicated to making the process fair and transparent for all. Their mission is to build a better world of renting for everyone, to get rid of the pain and complexity, and makes it more personal, flexible, and transparent. They make finding a home to love easy and enjoyable, with a personally curated search feature that gets to know the individual. It was incorporated in 2009 and is based in San Francisco, California.

Rocketrip

Series B in 2016
Rocketrip rewards employees for making flexible, cost-saving decisions when they travel for business while providing real-time insights into travel expenses — all with no disruption to your online booking process. A custom-calibrated Price to Beat and fully managed rewards store incentivize employees to choose lower-cost travel options. Rocketrip is trusted by enterprise brands like iHeartMedia, Feld Entertainment, and Twitter. It was founded in 2013 and headquartered in New York, United States.

World View Enterprises

Series B in 2016
World View Enterprises, Inc. provides space travel services to individuals for research, educational, and scientific pursuits. The company was incorporated in 2012 and is based in Tucson, Arizona.

Tizona Therapeutics

Series B in 2016
The company is establishing collaborations with its scientific founders “to better understand whether regulatory T cells play a more prominent role in certain tumors,” he added. Although research suggests that Tregs cells play a more prominent role in creating immunosuppression in the microenvironment in some tumor types than others, “quite honestly, the data are lacking. One of the ways we’re going to differentiate the company is to understand that relationship better.

Unchained Labs

Series B in 2016
Unchained Labs is a developer of life science biologics tools designed to help researchers break free from tools that just don't cut it. It offers a multiplex protein stability platform for biologics that measures a host of protein stability parameters. The company's products include protein sizing systems, stability quantifiers, benchtop workflow solutions, automated buffer exchanges, concentration liberators, particle identifiers, and more, enabling biologics researchers to speed up their work with ease. Unchained Labs was established in 2013 and is based in Pleasanton, California, USA.

Bellhop

Series B in 2015
Bellhops, Inc. is a rapidly growing moving services company based in Chattanooga, Tennessee, founded in 2013. It specializes in providing loading and unloading services for trucks, trailers, storage units, and mobile storage containers, as well as heavy lifting services. Bellhops connects college students with individuals and businesses in need of moving assistance through its user-friendly online platform and mobile application. The company caters to small and medium-scale moves and operates in 55 cities across the United States, with plans for further expansion. By leveraging technology, Bellhops aims to enhance customer experiences and offer competitive pricing compared to traditional moving services in the $18 billion industry.

Arvinas

Series B in 2015
Arvinas is a pharmaceutical company that focuses on developing novel therapeutics to treat a variety of diseases including cancer, pro-inflammatory, autoimmune and rare diseases. Its proprietary approach is the targeting of disease-causing proteins for degradation thus eliminating them from the body. The company was founded in 2013 and is headquartered in Connecticut, United States.

Antiva Biosciences

Series B in 2015
Antiva Biosciences is a biopharmaceutical company developing novel, localized therapeutics for the treatment of diseases caused by HPV infection. The company was founded as Hera Therapeutics in 2012 by Dr. Karl Hostetler at The University of California San Diego. They are now Antiva Biosciences which is headquartered in South San Francisco.

RealtyMogul

Series B in 2015
RealtyMogul is an online marketplace for real estate investing that connects investors who want to invest in real estate with institutional-quality real estate investments. Through the RealtyMogul platform that gives investors have the opportunity to invest in real estate opportunities online through a private, secure website. Investors can browse investments, review due diligence materials, and sign legal documents securely online. Once invested, investors have access to an investor dashboard, giving them 24/7 access to watch how their money is working for them. The company was founded in 2012 by Jilliene Helman and Justin Hughes and is based in Los Angeles, California.

Tubular Labs

Series B in 2015
Tubular is the leading global video measurement and analytics platform that powers broadcasters, publishers, and brands to create successful content and scale audiences faster. We provide the most complete picture of what video consumers watch and enable companies to grow digital audiences and sell brand integrations to win in the ever evolving world of video. Tubular’s software tracks over 4 Billion videos, 1 Trillion Views, 10 Million influencers, 90K brands, 40K media, and 48 Billion sponsored video views. In total, that’s over 350 Million more videos analyzed per month than our closest competitor. We know it’s not just about data, it’s about insights, and that’s why we’re trusted by 7 of the top 10 global media companies, who make strategic decisions every day based on Tubular software.

Glooko

Series B in 2015
Glooko is the universal diabetes platform that provides insights to improve outcomes for people with diabetes (PWDs) and their care teams. Glooko connects to the world’s most popular diabetes devices, major fitness and activity trackers and supplies personalized, timely patient information such as glucose level, food, insulin, medications, blood pressure, diet and weight data. Trusted by the world’s leaders in diabetes care, we are in over 7,000 clinical locations and used by over 1.5 million PWDs in 23 countries across 15 languages. Learn more by visiting www.glooko.com.

Beckon

Series B in 2015
Beckon, Inc. provides omnichannel analytics software for marketers. It provides performance analytics, visualization, and reporting solutions. The company’s software-as-a-service platform integrates marketing data and delivers dashboards and scorecards for cross-channel marketing intelligence. Beckon, Inc. was founded in 2011 and is based in San Mateo, California. As of November 19, 2018, Beckon, Inc. operates as a subsidiary of Aclate, Inc..

ALDEA Pharmaceuticals

Series B in 2014
ALDEA Pharmaceuticals is developing small-molecule modulators of the aldehyde dehydrogenase enzyme (ALDH) family, to treat toxic aldehyde-related diseases. This proprietary technology represents new product opportunities to address novel targets across multiple therapeutic areas. For example, an ALDH activator compound enhances the detoxification of acetaldehyde in the alcohol metabolism pathway, to treat acute symptoms and to reduce long-term tissue damage and cancer risk. The company was founded in 2011 and headquartered in Redwood City, California.

Turo

Series B in 2014
Turo Inc. operates an online car rental marketplace that connects local car owners with travelers looking to rent vehicles. Founded in 2009 and based in San Francisco, Turo allows car owners to list their cars for rental, offering a diverse selection of vehicles for travelers. Users can easily calculate potential earnings from renting their cars and enjoy access to unique vehicles at prices up to 40% lower than traditional car rental services. Since its national launch in 2012, Turo has cultivated a community of over 2 million users in the U.S. and Canada, allowing car owners to earn extra income while providing travelers with convenient rental options for local pickup, city delivery, and airport delivery. This platform not only facilitates car sharing but also enhances the overall travel experience by making a wide range of vehicles accessible in various locations.

Instacart

Series B in 2014
Instacart is a grocery delivery service that enables customers to receive groceries and home essentials at their doorstep, often within an hour. Founded in 2012 and headquartered in San Francisco, Instacart offers a wide selection of over 500,000 items from various local grocery stores, including well-known retailers such as Safeway, Whole Foods, and Costco. Customers can conveniently combine products from multiple stores into a single order, making the shopping experience more efficient. The company connects customers with individual shoppers who fulfill their orders, allowing for a personalized service. Instacart has garnered significant funding from various prominent investment firms, supporting its growth and expansion in the competitive grocery delivery market.

Metacloud

Series B in 2014
Metacloud is a cloud solutions provider specializing in OpenStack-based private clouds for enterprise clients. Established in 2010 by experienced architects from leading web commerce and technology firms, Metacloud focuses on deploying and supporting production clouds for Fortune 500 companies across various industries. The company is based in Pasadena, California, and serves as a corporate sponsor of the OpenStack Foundation, actively participating in and contributing to the OpenStack community. Metacloud distinguishes itself by offering a seamless cloud experience, prioritizing functionality over hardware, software, or consulting services.

Tubular Labs

Series B in 2014
Tubular is the leading global video measurement and analytics platform that powers broadcasters, publishers, and brands to create successful content and scale audiences faster. We provide the most complete picture of what video consumers watch and enable companies to grow digital audiences and sell brand integrations to win in the ever evolving world of video. Tubular’s software tracks over 4 Billion videos, 1 Trillion Views, 10 Million influencers, 90K brands, 40K media, and 48 Billion sponsored video views. In total, that’s over 350 Million more videos analyzed per month than our closest competitor. We know it’s not just about data, it’s about insights, and that’s why we’re trusted by 7 of the top 10 global media companies, who make strategic decisions every day based on Tubular software.

NatureBox

Series B in 2014
NatureBox, Inc. engages in the door delivery of snacks. Its service enables a user to order for snacks online and get them door delivered. The company provides non-GMO snacks, as well as vegan snacks, including dried fruits, nut mixes, and more. NatureBox, Inc. was founded in 2011 and is based in Redwood City, California.

CircleUp

Series B in 2014
CircleUp Network, Inc. operates an equity crowdfunding platform that connects accredited investors with early-stage consumer and retail brand entrepreneurs. Founded in 2011 and based in San Francisco, the company provides a modern approach to private markets by facilitating access to capital and resources for innovative consumer goods companies. Utilizing Helio, its proprietary machine learning platform, CircleUp analyzes vast amounts of data to evaluate potential investments and predict business success. The platform emphasizes sectors such as food, personal care, pet products, apparel, retail, and restaurants, allowing investors to discover and research promising brands. CircleUp’s investor base includes industry experts, venture capitalists, private equity professionals, and angel investors, all focused on identifying and supporting the growth of emerging consumer brands.

UrbanSitter

Series B in 2014
UrbanSitter, Inc. operates a childcare marketplace where parents and babysitters meet through shared connections. It is an online resource where parents go to find and book babysitters and nannies recommended by people they know. The company offers its services in San Francisco, New York City, Chicago, Los Angeles, Seattle, Washington D.C., Boston, Denver, and San Diego. UrbanSitter, Inc. was founded in 2010 and is based in San Francisco, California.

SureWaves

Series B in 2014
SureWaves MediaTech Private Limited specializes in media convergence solutions, primarily focusing on programmatic television advertising. Founded in 2006 and headquartered in Bengaluru, India, with additional offices in major cities and Dubai, the company offers Skynet, a marketplace that helps marketers plan and purchase audiences on broadcast TV channels, and the SureWaves Spot TV Network, which allows brands to reach untapped audiences on local cable and regional satellite channels. The company is known for its innovation, having filed over 40 patents related to its technology. It aims to create the SureWaves Media Grid, an integrated platform for ad aggregation, content delivery, network management, media planning, and reporting across various media formats. Led by a team with extensive experience in media and technology, SureWaves is recognized for its contributions to the digital out-of-home market and has successfully expanded into local television advertising.

India Property Online

Series B in 2013
India Property Online Private Limited operates an online platform that facilitates the buying, selling, and renting of properties across India. Established in 2006 and headquartered in Chennai, the platform enables builders, landowners, and landlords to list their properties for potential buyers and renters. The service caters to clients in major cities including Chennai, Bengaluru, Mumbai, Hyderabad, Delhi, and others. India Property Online is associated with Consim Info Pvt. Ltd, a prominent internet company recognized for its diverse offerings in various sectors such as matrimonial services and classifieds. The company has also formed partnerships with leading media organizations to enhance customer service and improve visibility for property listings. As of December 2018, it operates as a subsidiary of Quikr India Private Limited.

Corvium

Series B in 2013
Corvium, Inc. provides software solutions for food safety. It offers Control-Pro solutions that provides visualization, monitoring, analytics, and documentation of food safety testing and electromagnetic pulse testing lifecycle that reduces undetected contamination and recalls. The company also provides insights food solutions that monitors data flows and provides tailor-made food safety performance. It serves food processors, retailers, and consumers. Corvium, Inc. was formerly known as Sample6, Inc. and changed its name to Corvium, Inc. in August 2019. The company was founded in 2009 and is headquartered in Reston, Virginia with an additional office in Boston, Massachusetts.

Sample6

Series B in 2013
Sample6 is a biotechnology company that specializes in the development of a synthetic-biology based diagnostic system for bacteria. Its innovative technology enables enrichment-free detection of harmful bacteria, identifying levels as low as 1 CFU/ml within just four hours. The proprietary Bioillumination Platform, created by a team of researchers including Professor Tim Lu from MIT, allows for the engineering of bioparticles that target specific unwanted bacteria, illuminating them for detection. This system is coupled with sensitive sensor technology that provides rapid on-site results without the need for a laboratory. Sample6 aims to enhance public health and safety by enabling quick and efficient detection of harmful bacteria across various industries, including food production, retail, and healthcare, addressing environments where humans and bacteria interact.

Civitas Therapeutics

Series B in 2013
Civitas Therapeutics is a biopharmaceutical company dedicated to developing therapies for pulmonary delivery. The company focuses on creating innovative treatments for central nervous system and respiratory disorders, with a particular emphasis on conditions such as multiple sclerosis and spinal cord injuries. Civitas Therapeutics aims to improve the health and quality of life for patients across the United States through its specialized drug delivery systems.

JOOR

Series B in 2013
JOOR, Inc. operates an online global fashion marketplace for wholesale buying. It serves as a digital marketplace and data exchange that connects brands and retailers. JOOR, Inc. has a strategic partnership with ORDRE. The company was founded in 2010 and is based in New York, New York with additional offices in Los Angeles, California; London, United Kingdom; Milan, Italy; Paris, France; and Sydney and Melbourne, Australia.
MID has developed the FloShield system, a franchise of products that substantially improve visualization during laparoscopic surgery. During laparoscopic surgery, it is common for condensation to form on the end of the laparoscope obscuring vision. It is also common for debris from the ultrasonic scalpel, cautery, or even blood products themselves to degrade the surgical view. Most commonly, surgeons will need to remove the laparoscope for manual cleaning. It was founded in 2006 and headquartered in Columbus, Ohio.

Dermira

Series B in 2013
Dermira is a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and their patients. Dermira’s portfolio of five product candidates targets significant market opportunities. It was founded in 2010 and headquartered in Menlo Park, California.

WibiData

Series B in 2013
WibiData is a software company that specializes in big data applications aimed at helping enterprises create personalized experiences across various channels. Founded in 2010 in San Francisco under the name Odiago by Christophe Bisciglia, Aaron Kimball, and Garrett Wu, WibiData leverages open-source technologies such as Apache Hadoop, Apache Cassandra, Apache HBase, Apache Avro, and the Kiji Project. The company is supported by several notable investors, including Canaan Partners and New Enterprise Associates. Through its innovative platform, WibiData enables organizations to effectively analyze and utilize their data for enhanced customer engagement.

The RealReal

Series B in 2013
The RealReal, Inc. operates an online marketplace for consigned luxury goods. It offers various resale product categories, including women’s, men’s, kids’, jewelry, and watches, as well as home and art products. The company was founded in 2011 and is headquartered in San Francisco, California.
MID has developed the FloShield system, a franchise of products that substantially improve visualization during laparoscopic surgery. During laparoscopic surgery, it is common for condensation to form on the end of the laparoscope obscuring vision. It is also common for debris from the ultrasonic scalpel, cautery, or even blood products themselves to degrade the surgical view. Most commonly, surgeons will need to remove the laparoscope for manual cleaning. It was founded in 2006 and headquartered in Columbus, Ohio.

Theraclone Sciences

Series B in 2013
Theraclone Sciences, Inc. is a Seattle-based discovery-stage biotechnology company focused on developing novel therapeutic antibodies for the treatment of cancer and infectious diseases. The company utilizes its In-Situ Therapeutic Antibody Rescue technology to rapidly test human antibodies, identifying those with exceptional biological functions. Notable among its offerings is TCN-032, a recombinant human monoclonal antibody aimed at treating patients hospitalized with severe influenza. Theraclone’s antibody programs are in varying stages of preclinical and clinical development, targeting significant unmet medical needs such as triple negative and endocrine treatment-resistant HER-2 negative breast cancer, infectious disease-associated cancers, and multidrug-resistant bacteria. Theraclone was founded in 2004 and was formerly known as Spaltudaq Corporation, changing its name in March 2009. The company is privately held and has received venture funding from several investment firms.

Artspace

Series B in 2013
Artspace is the premier online retailer where collectors can purchase works by top contemporary artists directly from leading commercial galleries, prestigious cultural institutions, and non-profits. Our curators also commission works directly from the most renowned artists working today, working closely with their studios to produce exclusive limited editions. Our mission is to help both aspiring and experienced collectors discover, learn about, and acquire art while helping artists and the institutions that support them reach broader audiences worldwide. Proceeds from many of the works on our site benefit these esteemed institutions and artists.

ShopKeep

Series B in 2012
ShopKeep Inc. offers a comprehensive point-of-sale solution tailored for small and medium-sized businesses (SMBs). Founded in 2008 and headquartered in New York, with additional offices in Portland, Northbrook, and Belfast, the company provides cloud-based software and hardware, including card readers, receipt printers, and Bluetooth scanners, specifically designed for iPad use. Its system facilitates secure payment processing, inventory management, and employee tracking, while also offering real-time reporting and analytics. ShopKeep’s services extend to a merchant cash advance program, a marketing dashboard for tracking customer engagement, and a mobile app that allows business owners to monitor performance remotely. With a customer support team available 24/7, ShopKeep serves a diverse range of establishments, including cafes, retail shops, and food trucks across the United States, Canada, and Guam. As of late 2020, ShopKeep operates as a subsidiary of Lightspeed POS Inc.

CytomX Therapeutics

Series B in 2012
CytomX Therapeutics is an early stage, privately-funded biotechnology company developing Probodiesâ„¢, proteolytically-activated antibodies. Probodies, by their ability to site-direct the activity of antibodies, will result in an improved therapeutic index for validated targets as well enable the drugging of targets with broad tissue expression. Their mission, alone and with the help of partners, is to provide patients with more effective and less toxic therapies for severe illnesses such as cancer and inflammatory diseases.

onefinestay

Series B in 2012
onefinestay is a hospitality service that connects homeowners with guests seeking unique accommodations. Founded in London in 2009, the company specializes in offering high-quality homes for short-term rentals, allowing homeowners to earn additional income while they are away. onefinestay handles all aspects of the rental process, including marketing, guest bookings, and on-site support. Guests are provided with an authentic local experience, as they can stay in distinctive homes and enjoy personalized service throughout their stay. The company has expanded its operations to major cities including Paris, New York, and Los Angeles, aiming to redefine the hospitality landscape by promoting a new category of accommodation. Through its commitment to excellence, onefinestay seeks to enhance the travel experience for guests while providing homeowners with peace of mind.

Ambra Health

Series B in 2012
Ambra Health is a medical data and image management software-as-a-service company that provides a cloud-based platform for healthcare providers. The platform is designed to enhance imaging innovation and improve collaborative care workflows by offering secure and easy access to medical images. It serves a diverse clientele, including major health systems and radiology practices, enabling them to streamline their operations and enhance patient care. Ambra Health's solutions focus on agility, interoperability, and user-friendly design, allowing organizations to adopt and integrate the technology effectively while improving business outcomes. The company aims to meet the evolving needs of the healthcare industry by delivering innovative medical image management solutions.

SilverRail

Series B in 2012
SilverRail Technologies AB is an information technology company that specializes in providing software solutions for the rail and ground transport sectors. Founded in 2000 and based in Stockholm, Sweden, the company offers a comprehensive suite of products designed to enhance the passenger experience, covering areas such as inventory management, sales, distribution, operations, and settlement. SilverRail's platform connects rail carriers and travel retailers, facilitating both online and offline ticket distribution. The technology aims to simplify access to global rail content for passengers, integrating services like journey planning, pricing, booking, payment, and reporting. Originally known as Linkon AB, the company rebranded to SilverRail Technologies AB in 2018 and operates as a subsidiary of SilverRail Linkon AB.

Transcend Medical

Series B in 2012
Transcend Medical, Inc., an ophthalmic device company, engages in the development of medical devices for the treatment of glaucoma. The company offers CyPass Micro-Stent, a micro-invasive tent that is inserted in the eye during routine cataract surgery; Vold Gonio Lens for use in micro-invasive glaucoma surgery. It also provides clinical trial services. Transcend Medical, Inc. was formerly known as iART Newco I, Inc. The company was founded in 2005 and is based in Menlo Park, California. As of March 23, 2016, Transcend Medical, Inc. operates as a subsidiary of Alcon Holdings, Inc.

Elevation Pharmaceuticals

Series B in 2012
Founded in 2008, Elevation Pharmaceuticals is developing a pipeline of improved aerosol drug products for COPD patients. There founding team has a successful track record starting companies and building dedicated teams to develop new drug products that improve patients' lives. At Elevation, they have a disciplined approach to strategic decision-making that helps us stay focused on the path with the highest probability of success. They are executing our drug development plans with passion, integrity, and a high sense of urgency in order to meet the needs and expectations of our stakeholders -- employees, investors, partners, and patients.

Theraclone Sciences

Venture Round in 2011
Theraclone Sciences, Inc. is a Seattle-based discovery-stage biotechnology company focused on developing novel therapeutic antibodies for the treatment of cancer and infectious diseases. The company utilizes its In-Situ Therapeutic Antibody Rescue technology to rapidly test human antibodies, identifying those with exceptional biological functions. Notable among its offerings is TCN-032, a recombinant human monoclonal antibody aimed at treating patients hospitalized with severe influenza. Theraclone’s antibody programs are in varying stages of preclinical and clinical development, targeting significant unmet medical needs such as triple negative and endocrine treatment-resistant HER-2 negative breast cancer, infectious disease-associated cancers, and multidrug-resistant bacteria. Theraclone was founded in 2004 and was formerly known as Spaltudaq Corporation, changing its name in March 2009. The company is privately held and has received venture funding from several investment firms.

CallmyName

Series B in 2011
Callmyname delivers the most powerful cloud-based social communicator. It brings excitement & productivity back to their everyday communication by providing people & businesses the freedom to reach each other using meaningful names and by enriching each such interaction with just-in-time relevant info. Founded in 2007, CallMyName enables every individual to establish a cool "Personal mobile identity" making it the one way to reach him and to view his live social "doing" on every mobile or PC platform. Thanks to CallmyName unique social digest abilities people automatically get highly relevant up-to-date info with every incoming or outgoing communication and can reach millions of businesses much faster simply by "calling" their names, without having them in their phone book. Much like domain names enabled the Internet revolution, their call-name mobile domains are once again rewriting the rules of mobile communication, offering a 1-on-1 experience that is faster and more effective than mobile directories or search engines out there.

Naaptol

Series B in 2011
Naaptol Online Shopping Private Limited operates an online shopping portal for shoppers, merchants, and market enthusiasts in India. The company offers products in the categories of men and women clothing, footwear and bags, mobiles, tablets and computers, home and kitchen, jewelry and watches, home decor, automobiles, consumer electronics, toys and nursery, health and beauty, sports and fitness, gifts and stationery, alliances, and others. The company was founded in 2008 and is based in Navi Mumbai, India with additional offices in Delhi and Jaipur, India.

Virsto Software

Series B in 2011
Virsto Software, founded in late 2007 by experts in storage and virtualization, focuses on developing innovative virtual storage solutions designed for virtual servers and data centers. The company offers Virsto One, a hypervisor-based storage virtualization software that allows organizations to optimize storage-intensive workloads. This solution enhances the consolidation of server and storage hardware while simplifying storage management. By addressing the increasing demand for cost-effective and efficient storage in the virtual computing landscape, Virsto's technology helps organizations improve performance, lower storage capital and operational costs, and streamline data management processes.

Transcend Medical

Series B in 2011
Transcend Medical, Inc., an ophthalmic device company, engages in the development of medical devices for the treatment of glaucoma. The company offers CyPass Micro-Stent, a micro-invasive tent that is inserted in the eye during routine cataract surgery; Vold Gonio Lens for use in micro-invasive glaucoma surgery. It also provides clinical trial services. Transcend Medical, Inc. was formerly known as iART Newco I, Inc. The company was founded in 2005 and is based in Menlo Park, California. As of March 23, 2016, Transcend Medical, Inc. operates as a subsidiary of Alcon Holdings, Inc.

Virsto Software

Series B in 2011
Virsto Software, founded in late 2007 by experts in storage and virtualization, focuses on developing innovative virtual storage solutions designed for virtual servers and data centers. The company offers Virsto One, a hypervisor-based storage virtualization software that allows organizations to optimize storage-intensive workloads. This solution enhances the consolidation of server and storage hardware while simplifying storage management. By addressing the increasing demand for cost-effective and efficient storage in the virtual computing landscape, Virsto's technology helps organizations improve performance, lower storage capital and operational costs, and streamline data management processes.

CarTrade

Series B in 2011
CarTrade.com is India’s leading online automotive market for buyers and sellers of new and used vehicles. Our car auctions take place across more than 80 cities with over 1200 dealers participating in these auctions. This enables us to empower the buyers and the seller to choose the most suitable vehicles at the most affordable prices.

Zuberance

Series B in 2010
Backed by top-tier investors (Canaan, Emergence, and Correlation), Zuberance provides an award-winning social marketing platform that leading brands use to identify and mobilize their Brand Advocates, driving qualfied leads, sales, and positive Word of Mouth. Zuberance is the leading social media marketing company focused on Brand Advocates. Zuberance’s award-winning social media marketing solution enables companies to systematically identify and energize their highly-satisfied customers (AKA “Brand Advocates”), driving measurable increases in referral leads, recommendations, and revenues. For more information, visit http://www.zuberance.com or follow Zuberance on Twitter @zuberance. Zuberance is a member of the International Health, Racquet & Sportsclub Association (IHRSA) and the Word of Mouth Marketing Association (WOMMA.)

Tobira Therapeutics

Series B in 2010
Tobira Therapeutics, Inc., a biotechnology company, engages in the research, discovery, acquisition, development, and commercialization of antiviral compounds for the treatment of life-threatening and life-altering infectious diseases. It develops TBR-652 and TBR-220 antagonists for the treatment of HIV/AIDS, hepatitis, and other associated infectious conditions. The company was founded in 2006 and is based in Princeton, New Jersey.

OpenSky

Series B in 2010
OpenSky OpenSky is a social platform that makes commerce more instant, open and connected. Founded by [John Caplan](http://www.crunchbase.com/person/john-caplan) and [Kevin Ambrosini](http://www.crunchbase.com/person/kevin-ambrosini-2), OpenSky has been named one of The World’s 50 Most Innovative Companies (alongside Apple, Facebook, Google, Amazon, Twitter, Square, Airbnb, Dropbox and Kickstarter) by Fast Company and one of America's Most Promising Companies by Forbes.

Gemvara

Series B in 2010
Gemvara, Inc. manufactures and sells custom-made fine jewelry for women and men through an online store. Its product categories include gemstone and diamond engagement rings; wedding rings and jewelry; and created rings, necklaces, and diamond studs. Gemvara, Inc. was formerly known as Paragon Lake, Inc. and changed its name to Gemvara, Inc. in February 2010. The company was founded in 2006 and is based in Boston, Massachusetts. As of April 27, 2016, Gemvara, Inc. operates as a subsidiary of Richline Group, Inc.

Kabam

Series B in 2009
Kabam, an entertainment company, develops free-to-play games for mobile devices and Web platforms. It offers traditional, social, strategy, action, arcade, sports, and role-playing games. Holly Liu, Kevin Chou, Mike Li, and Wayne Chan founded Watercooler on October 28, 2006 that became Kabam in August 2010, with its headquarters in San Francisco in California. It has additional offices in San Francisco and Los Angeles in California, Vancouver in Canada, Austin in Texas, Beijing in China, London in United Kingdom, and Berlin in Germany.

Transcend Medical

Series B in 2009
Transcend Medical, Inc., an ophthalmic device company, engages in the development of medical devices for the treatment of glaucoma. The company offers CyPass Micro-Stent, a micro-invasive tent that is inserted in the eye during routine cataract surgery; Vold Gonio Lens for use in micro-invasive glaucoma surgery. It also provides clinical trial services. Transcend Medical, Inc. was formerly known as iART Newco I, Inc. The company was founded in 2005 and is based in Menlo Park, California. As of March 23, 2016, Transcend Medical, Inc. operates as a subsidiary of Alcon Holdings, Inc.

Marinus Pharmaceuticals

Series B in 2009
Marinus Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to the development and commercialization of ganaxolone, offering a new mechanism of action with safe and convenient dosing, for adult and pediatric patient populations in acute and chronic care settings. The company was founded in 2003 and is based in Branford, Connecticut.